Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1  by Harbour, J.William et al.
Cell, Vol. 98, 859±869, September 17, 1999, Copyright 1999 by Cell Press
Cdk Phosphorylation Triggers Sequential
Intramolecular Interactions that Progressively
Block Rb Functions as Cells Move through G1
Wang, 1996). Phosphorylation of S-807, S-811, T-821,
T-826, and S-780 leads to disruption of binding to E2F
(Knudsen and Wang, 1997), which does not contain an
LXCXE sequence.
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and this interaction is required for kinase activity (Nor-Washington University School of Medicine
bury and Nurse, 1992; Reed, 1992; Nasmyth, 1993; Mor-St. Louis, Missouri 63110
gan, 1995). Rb can be phosphorylated by several differ-
ent cyclin±Cdk combinations, including D cyclins (D1,
D2, and D3) in combination with Cdk4 or Cdk6, cyclinSummary
E associated with Cdk2, and cyclin A associated with
Cdk2 or Cdc2 (Hinds et al., 1992; Dowdy et al., 1993;We present evidence that phosphorylation of the
Ewen et al., 1993; Kato et al., 1993; Hatakeyama et al.,C-terminal region of Rb by Cdk4/6 initiates successive
1994; Mittnacht et al., 1994; Roberts et al., 1994; Oht-intramolecular interactions between the C-terminal
subo et al., 1995; Weinberg, 1995). Phosphorylation byregion and the central pocket. The initial interaction
cyclin D±Cdk4/6 and cyclin E±Cdk2 occurs during G1,displaces histone deacetylase from the pocket, blocking
whereas cyclin A is not expressed until S phase, andactive transcriptional repression by Rb. This facilitates
thus cyclin A±Cdk complexes may serve to add to ora second interaction that leads to phosphorylation of
maintain phosphorylation of Rb during S phase (Sherr,the pocket by Cdk2 and disruption of pocket structure.
1996). However, the Cdks that actually phosphorylateThese intramolecular interactions provide a molecular
Rb in vivo and the phosphoacceptor sites for these ki-basis for sequential phosphorylation of Rb by Cdk4/6
nases are still unclear, as is the precise mechanismand Cdk2. Cdk4/6 is activated early in G1, blocking
by which phosphorylation regulates Rb activity. Recentactive repression by Rb. However, it is not until near
studies indicate that a ªknock inº of the cyclin E genethe end of G1, when cyclin E is expressed and Cdk2
into the cyclin D1 locus completely reverses the pheno-is activated, that Rb is prevented from binding and
type of the cyclin D1 gene knockout (Geng et al., 1999),inactivating E2F.
suggesting that cyclin E is a major downstream target
of cyclin D1 and thus Rb repressor activity. These results
then provide a molecular explanation of the sequentialIntroduction
expression of cyclin D1 and cyclin E during the cell
cycle.Control of the G1 to S phase transition in the cell cycle is
Cdk4/6 becomes active before Cdk2 during G1, andan important checkpoint in regulating cell proliferation.
recent evidence suggests that phosphorylation of RbOne regulator of this transition is the retinoblastoma
by Cdk4/6 may be required for its subsequent phosphor-protein (Rb) (Ewen, 1994; Weinberg, 1995). Rb can bind
ylation by Cdk2 (Ezhevsky et al., 1997; Lundberg andto the E2F family of transcription factors (Chellappan et
Weinberg, 1998). Other studies also support the ideaal., 1991; Nevins, 1992; La Thangue, 1994; Lam and La
that full hyperphosphorylation of Rb may require multi-Thangue, 1994; Adams and Kaelin, 1996; Slansky and
ple Cdks (Hatakeyama et al., 1994; Zarkowska and Mitt-Farnham, 1996; Dyson, 1998), and the resulting Rb±E2F
nacht, 1997). The initial phosphorylation by Cdk4/6 onlyinteraction not only blocks transcriptional activation by
appears to be responsible for a portion of the phosphor-
E2F but also forms an active transcriptional repressor
ylation of Rb that occurs during G1, and progressive
complex at the promoter of cell cycle genes that can
phosphorylation by both Cdk4/6 and Cdk2 seems to be
block transcription by recruiting histone deacetylase necessary for hyperphosphorylation of Rb and a block
(HDAC) and remodeling chromatin (Weintraub et al., of growth arrest (Lundberg and Weinberg, 1998). The
1992; Brehm et al., 1998; Luo et al., 1998; Magnaghi et targets of Cdk4/6 and Cdk2 phosphorylation in vivo are
al., 1998). Recent studies suggest that interaction of the still unclear, as is the mechanism through which phos-
Rb±E2F repressor complex with cell cycle control genes phorylation by Cdk4/6 may facilitate subsequent phos-
is important for growth arrest by Rb (Zhang et al., 1999). phorylation by Cdk2. In addition to the G1/S transition,
The ability of Rb to interact with E2F and to repress Rb also seems to regulate progression through S phase,
transcription is regulated by phosphorylation catalyzed but there are conflicting results as to whether interaction
by cyclin-dependent kinases (Cdks). Rb contains at least of Rb with E2F is required for S phase regulation (Chew
16 consensus sequences for Cdk phosphorylation, but et al., 1998; Knudsen et al., 1998). Phosphorylation by
the significance of all of these sites is still unclear. It the different Cdks may then regulate Rb functions in
has been demonstrated that phosphorylation of S-807 different points of the cell cycle.
or S-811 blocks binding of Rb to c-Abl and that phos- Here, we present evidence that phosphorylation of
phorylation of T-821 or T-826 disrupts interaction with Rb by G1 Cdks leads to successive intramolecular inter-
proteins containing the sequence LXCXE (Knudsen and actions that initially block HDAC binding to the pocket
and thus active transcriptional repression and then dis-




Figure 1. The Phosphorylated C-Terminal Re-
gion of Rb Displaces HDAC from the Pocket
(A) The Rb C-terminal region contains dock-
ing sites for cyclin±Cdks (ªCdkº) (Adams et
al., 1999) and Cdk phosphoacceptor sites
(ªPº) (Knudsen and Wang, 1996, 1997; Whi-
taker et al., 1998; Adams et al., 1999), and
both are required for Cdk inhibition of Rb re-
pressor activity. Rb fused to the DNA-binding
domain of Gal4 (Weintraub et al., 1995) was
coexpressed in Rb(2) C33a cells with the
pSVEC-G reporter containing Gal4-binding
sites upstream of the SV40 enhancer (Chow
and Dean, 1996; Chow et al., 1996) to assay
active transcription repression by Rb. CAT
activity from the reporter was assayed as de-
scribed (Weintraub et al., 1995). ªcycº indi-
cates cyclin. Rb(A1B) contains only the A±B
pocket (amino acids 379±792). In RbCD4,
S-807, S-811, T-821, and T-826, Cdk phos-
phoacceptor sites (P) are mutated to alanine.
Rb(882) is truncated at amino acid 882. ªdn-
Cdk2º indicates an expression vector for
dominant-negative Cdk2 (van den Heuvel and
Harlow, 1993).
(B) The C-terminal region of Rb in trans can
block pocket repressor activity. Transfec-
tions were done as in (A). ªC,º ªCD4,º and
ªCD2º indicate that the C-terminal region, the
C-terminal region with the CD4 mutation, or
the C-terminal region with the CD2 mutation,
respectively, were coexpressed in trans.
(C) The phosphorylated C-terminal region of
Rb displaces HDAC1 from the pocket. Ex-
pression vectors for HDAC1 fused to a LexA
tag (L-HDAC), the C-terminal region (amino
acids 792±928) fused to LexA (L-C), the Rb
small pocket (amino acids 379±792) fused to
a Gal4 tag (G-Sp), cyclin D (cyc D), or cyclin E (cyc E) were cotransfected into C33a cells. G-Sp was immunoprecipitated and associated
L-HDAC and L-C were detected by Western blot as described (Luo et al., 1998).
(D) Direct Western blot of L-HDAC and L-C. ªpCº indicates the more slowly migrating phosphorylated form of the C-terminal region.
(E) Direct Western blot for immunoprecipitated G-Sp.
Results had no effect on repressor activity, but this mutation
also prevented the block in repression by the G1 Cdks
(Figure 1A).Mutation of Phosphoacceptor Sites or Deletion
of Cdk Docking Sequences in the C-Terminal
Region of Rb Prevents a Cdk-Mediated Block The C-Terminal Region of Rb Can Act in trans
to Block Repression by the Pocket Domainin Repressor Activity
The central pocket domain of Rb (amino acids 379±792) How does phosphorylation of the C-terminal region of
Rb inhibit active repression by the pocket? One possibil-is sufficient for active transcriptional repression (Wein-
traub et al., 1995; Chow and Dean, 1996; Chow et al., ity is that phosphorylation of the C-terminal region
causes a conformational change that disrupts the adja-1996). Even though the pocket contains consensus Cdk
phosphoacceptor sites, the repressor activity of this cent pocket. As another possibility, the C-terminal
region, when phosphorylated, may interact with theregion is not inhibited by Cdks; however, when the
C-terminal region of Rb (amino acids 792±928) is in- pocket, blocking its repressor activity. In the first model,
the C-terminal region might only function in cis (whencluded with the pocket and G1 Cdks are activated by
expression of their cyclin regulator subunits, active re- fused to the pocket); however, in the second model, the
C-terminal region may be able to block pocket repressorpression is inhibited (Figure 1A) (Chow and Dean, 1996).
The C-terminal region contains docking sites for both activity when expressed in trans (on a separate protein).
To distinguish between these mechanisms, the pocketcyclin D and cyclin E within the region C-terminal to
amino acid 870 (Adams et al., 1999). Deletion to amino and the C-terminal region were coexpressed on sepa-
rate proteins along with cyclin D, and active transcrip-acid 882 (D882) removes all of the cyclin D docking sites
and all but one potential cyclin E docking site. This tional repressor activity was analyzed. This expression
of the C-terminal region in trans along with cyclin DD882 mutation did not affect repressor activity, but it
prevented the inhibition of active repression by Rb when efficiently blocked repression by the pocket (Figure 1B).
Above, we demonstrated that the CD4 mutation of phos-either cyclin D or E was expressed (Figure 1A). Likewise,
mutation of four Cdk phosphoacceptor sites in the phoacceptor sites in the C-terminal region of Rb pre-
vented cyclin D±Cdk4/6 from blocking repressor activityC-terminal region (S-807, S-811, T-821, and T-826) (CD4)
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(Figure 1A); however, we found that expression of the
wild-type C-terminal region in trans restored the ability
of cyclin D±Cdk4/6 to block repressor activity of Rb
containing the CD4 mutation (Figure 1B). It has been
demonstrated that mutation of T-821 and T-826 pre-
vents G1 cyclins from blocking binding of Rb to LXCXE
proteins (Knudsen and Wang, 1996). We found that intro-
duction of this CD2 mutation into the C-terminal region
in trans (as with the CD4 mutation) prevented derepres-
sion by cyclin D expression (Figure 1B), providing further
evidence that binding to LXCXE proteins (such as HDAC)
is important for active repression by Rb.
The above results demonstrate that the phosphory-
lated C-terminal region of Rb in trans can block repres-
sor activity of the pocket, suggesting that phosphoryla-
tion of the C-terminal region may cause it to interact
with the pocket and disrupt pocket activity.
The Phosphorylated C-Terminal Region Inhibits
HDAC Binding to the Pocket
Active transcriptional repression by the Rb pocket is
mediated at least in part by recruiting members of the Figure 2. Sequential Mutations in the Lysine Patch surrounding the
LXCXE-Binding Site in Pocket Domain B Prevent a Cdk-Mediatedhistone deacetylase (HDAC) family (Brehm et al., 1998;
Block in Rb Repressor ActivityLuo et al., 1998; Magnaghi et al., 1998). These enzymes
Transfections were as in Figures 1A and 1B. Lysine to alanine muta-remove inhibitory acetyl groups from the amino-terminal
tions were created sequentially in lysine residues surrounding theregions of histone octamers, thereby promoting nucleo-
LXCXE-binding site (numbers indicate mutated lysine residues). ªCºsome assembly that inhibits transcription by limiting ac-
indicates expression of the C-terminal region in trans. Similar results
cessibility of transcription factors to the promoter (Has- were seen with cyclin E expression.
sig et al., 1997). HDAC1 and -2 contain an LXCXE-like
sequence that interacts with the LXCXE-binding site in
domain B of the Rb pocket (Brehm et al., 1998; Magnaghi residues (Lee et al., 1998). We reasoned that this posi-
et al., 1998). E2F binds a separate site on Rb, allowing tively charged ªlysine patchº might be a target of phos-
Rb to be tethered to a promoter through interaction with phoacceptor sites in the C-terminal region, thereby in-
E2F while simultaneously binding to HDAC (Brehm et hibiting HDAC from binding the LXCXE site. A series of
al., 1998). lysine patch mutations were created in Rb at K-713,
Since the phosphorylated C-terminal region blocks K-720, K-722, and K-729. While none of the mutations
active repression and T-821 and T-826, which regulate affected transcriptional repression, we observed a pro-
binding to LXCXE proteins, are required for this block, gressive loss in the ability of Cdk to block Rb repressor
we wondered whether the C-terminal region might in- activity as more lysine residues were mutated (Figure 2).
hibit HDAC binding to the pocket. Using coimmunopre- Thus, we suggest that cyclin D±Cdk4/6 phosphorylates
cipitation assays, we found that coexpression of cyclin sites in the C-terminal region that then interact with
D with the C-terminal region in trans inhibited binding lysine residues encircling the LXCXE-binding site in do-
of HDAC1 to the pocket (Figures 1C±1E). Interestingly, main B, preventing HDAC binding and thereby blocking
coexpression of cyclin D with the C-terminal region re- active transcriptional repression.
sulted in a more slowly migrating phosphorylated form
of the C-terminal region, and preferential binding of this
Cyclin D±Cdk4/6 Can Block Active Repression byphosphorylated form to the pocket coincided with inhi-
the Pocket, but Cyclin E±Cdk2 Is Necessary tobition of HDAC1 binding (Figure 1C). These results sug-
Prevent Rb from Binding and Inhibiting E2Fgest that the phosphorylated C-terminal region can bind
Cyclin D±Cdk4/6 becomes active early during G1, whileto the pocket and inhibit HDAC binding. It is of note,
cyclin E±Cdk2 activity peaks near the end of G1 (Sherr,however, that in the absence of cyclin expression the
1996). Phosphorylation of Rb by cyclin D±Cdk4/6 seemsunphosphorylated C-terminal region also bound to the
to be necessary for its subsequent phosphorylation bypocket, and expression of cyclin E prevented binding
cyclin E±Cdk2, and the activity of both kinases is re-of HDAC to the pocket without binding of the phosphory-
quired for complete hyperphosphorylation of Rb (Ezhev-lated C-terminal region to the pocket (Figure 1C). These
sky et al., 1997; Lundberg and Weinberg, 1998). Ourlatter points will be discussed in detail later in the paper.
above results suggested that expression of cyclin D and
thus activation of cyclin D±Cdk4/6 is sufficient to inhibit
binding of HDAC to the pocket, leading to a block inA Lysine Patch Encircling the LXCXE-Binding
Site in Pocket Domain B Is a Target of the active repression. However, expression of cyclin D was
inefficient at preventing Rb from inactivating E2F whenPhosphorylated C-Terminal Region
The crystal structure of the pocket shows that the a reporter containing a minimal promoter with E2F sites
was analyzed (Figure 3A). In contrast, expression ofLXCXE-binding site in domain B is encircled by six lysine
Cell
862
Figure 3. Cyclin E±Cdk4/6 but Not Cyclin
D±Cdk4/6 Can Prevent Inactivation of E2F
by Rb
(A) Expression of cyclin E but not cyclin D
blocks inactivation of E2F by Rb. A minimal
promoter containing a TATA box and E2F
sites (Weintraub et al., 1992) was cotrans-
fected into Rb(2) C33a cells along with ex-
pression vectors for Rb and cyclin D or E.
(B) Expression of cyclin E is required to dis-
rupt the interaction between Rb and E2F-1.
Rb (tagged with Gal4) was immunoprecipi-
tated with a Gal4 antibody, and then precipi-
tated proteins were Western blotted for asso-
ciated E2F-1. ªcycº indicates cyclin. The two
blots below show direct Westerns for input
E2F-1 and precipitated G-Rb.
(C) Cyclin E±Cdk2 has an additional inhibitory
effect on repression by Rb that does not re-
quire phosphoacceptor sites in the C-termi-
nal region or the lysine patch in the pocket.
The pocket domain of Rb fused to the DNA-
binding domain of Gal4 was coexpressed in
Rb(2) C33a cells with the pSVEC-G reporter
containing Gal4-binding sites upstream of the
SV40 enhancer to assess active transcription
repression as in Figures 1A and 1B. ªcycº
indicates cyclin; A 1 B D is the pocket with
lysine patch mutations; and ªCº indicates the
C-terminal region in trans, CD4 the C-terminal
region in trans with four phosphoacceptor
sites mutated, and ªCD2º the C-terminal re-
gion with T-821 and T-826 mutated.
cyclin E and thus activation of cyclin E±Cdk2 more effi- Cyclin E±Cdk2 Has a Novel Inhibitory Effect
on Pocket Activityciently inhibited the inactivation of E2F by Rb. Similarly,
Even though expression of cyclin D was more effectivein coimmunoprecipitation experiments, expression of
than expression of cyclin E in blocking active repressioncyclin E but not cyclin D was able to inhibit Rb±E2F
by Rb when the C-terminal region was in cis, cyclin Einteraction (Figure 3B). Therefore, we conclude that inhi-
was equally effective as cyclin D when the C-terminalbition of HDAC binding (and thus blocking active repres-
region was expressed in trans (Figures 1A and 3C).sion) as a result of cyclin D±Cdk4 phosphorylation of the
These results suggest that the activity of cyclin E±Cdk2C-terminal region is a separate event from inactivation of
is somehow constrained when the C-terminal region is inE2F (which requires cyclin E±Cdk2). Indeed, expression
cis, and this constraint is removed when the C-terminalof a dominant-negative form of Cdk2 along with cyclin
region is expressed in trans. Additionally, cyclin E±Cdk2D had no effect on the block of Rb repressor activity
was not as efficient as cyclin D±Cdk4/6 in phosphorylat-even though it did block the effect of cyclin E (Figure
ing the C-terminal region in vivo (Figures 1C and 1D).1A), suggesting that Cdk2 activity is not required for
Together, these results suggested that, when the C-ter-
cyclin D±Cdk4/6 to block active repression by Rb.
minal region is expressed in trans, cyclin E±Cdk2 may
Even though expression of cyclin D alone had no ef- be able to block Rb activity through a mechanism dis-
fect on Rb±E2F interaction, coexpression of cyclin D tinct from that of cyclin D±Cdk4/6 and independent of
with cyclin E resulted in further disruption of the Rb±E2F C-terminal phosphorylation.
complex and a further inhibition of E2F activity (Figures We reasoned that if inhibition of HDAC binding by the
3A and 3B). These results suggest that cyclin D±Cdk4/6 phosphorylated C-terminal region were the only mecha-
may facilitate the inhibitory effect of cyclin E±Cdk2 on nism by which Cdks block Rb repressor activity, then
Rb±E2F interaction and thus on E2F activity. Our results the C-terminal region in trans with phosphorylation sites
then reaffirm the previous notion that cyclin E±Cdk2 has mutated should not block repression. Indeed, this was
an additional effect on Rb, and we initiated studies to the case when cyclin D was expressed, but expression
of cyclin E still led to derepression with either CD4 orexamine how cyclin E±Cdk2 affects Rb function.
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CD2 in trans (Figure 3C). Likewise, expression of cyclin
E also resulted in a block of repressor activity when the
C-terminal region in trans was coexpressed with the
lysine patch mutant. We concluded that cyclin E±Cdk2
has an additional inhibitory effect on Rb that is distinct
from inhibition of HDAC binding. This novel activity, in
the context of full-length Rb, is dependent upon prior
interaction between the lysine patch and the phosphory-
lated C-terminal region, but this activity becomes consti-
tutive and independent of these sequences when the
C-terminal region is expressed in trans. Based on these
results, we suggest that the initial cyclin D-Cdk4/6-medi-
ated phosphorylation of the C-terminal region and its
subsequent interaction with domain B removes a steric
constraint imposed on the C-terminal region when it is
in cis, thereby bringing it into proximity of the pocket.
This allows cyclin E±Cdk2, docked to the C-terminal
region, to further act on the pocket. Expression of the
C-terminal region in trans removes the steric constraint
and thus eliminates the need for the initial interaction
between the phosphorylated C-terminal region and the
lysine patch in domain B.
The C-Terminal Region Facilitates Cyclin E±Cdk2
Phosphorylation of S-567 in the Pocket
If relief of steric constraint is all that is required for cyclin
E±Cdk2 to block repressor activity by the pocket, it is
unclear why the C-terminal region is required, either in
cis or in trans, for cyclin E±Cdk2 to phosphorylate the
pocket and block repressor activity. We concluded that
in addition to inhibiting HDAC binding, the C-terminal
region must have another role in inactivating the pocket
through a second cyclin E-Cdk2-dependent mechanism.
It seemed likely that this second activity of the C-ter-
minal region might be to facilitate phosphorylation of
the pocket by cyclin E±Cdk2. To address this possibility,
Figure 4. The C-Terminal Region Binds to the Rb Pocket Facilitatingwe performed in vitro phosphorylation assays (Figure
Phosphorylation of S-567
4A). When cyclin E±Cdk2 was incubated with the pocket
(A) Rb(A1B) and the C-terminal region purified from bacteria were
alone in a 60 min reaction, phosphorylation of the pocket incubated as indicated with cyclin E±Cdk2 (expressed in baculovi-
was evident, but inclusion of the C-terminal region in rus) in the presence of [32P]ATP, and proteins were separated by
trans did not significantly increase the phosphorylation. SDS-gel electrophoresis. ª60 and 75 minº indicates kinase reaction
time. Rb(A1B)D is the Rb pocket with phosphoacceptor sites atMutation of all of the phosphoacceptor sites in the
amino acids 608, 612, 780, and 788 mutated (S-567 is the onlypocket with the exception of S-567 eliminated this phos-
remaining consensus site).phorylation of the pocket. When the reaction time was
(B) Binding of phosphorylated and unphosphorylated C-terminal
increased to 75 min, we noticed that inclusion of the region to the pocket in vitro appears additive. ªE/K2º indicates cyclin
C-terminal region in trans now resulted in increased E±Cdk2.
phosphorylation of the pocket. We found that the pocket (C) Phosphorylated C-terminal region binds to the pocket. Phos-
phorylation of the C-terminal region in vitro causes the same mobilitycontaining S-567 as the only Cdk consensus phos-
shift seen in vivo (Figure 1C). ªIPº indicates that the complex be-phoacceptor site was phosphorylated in a C-terminal-
tween the pocket and the C-terminal region was immunoprecipi-dependent fashion. These results suggest that other
tated with an anti-pocket antibody, and the precipitated proteins
phosphoacceptor sites in the pocket are phosphory- were Western blotted with anti-C-terminal region antibody. ªBeadsº
lated directly by cyclin E±Cdk2, but phosphorylation of indicates input GST-C, either unphosphorylated or phosphorylated,
S-567 only occurs when the C-terminal region is present. that was bound to glutathione beads and Western blotted with anti-
C-terminal region antibody.The finding that the other sites are not dependent upon
the C-terminal region for phosphorylation suggested
that binding of the C-terminal region to the pocket may
not simply bring cyclin E±Cdk2 to the pocket; this bind- 1A), did not prevent this region from augmenting phos-
phorylation of the pocket by cyclin E±Cdk2 (Figure 4A).ing may facilitate access of cyclin E±Cdk2 to S-567,
which is normally buried in the A±B interface (Lee et al., We conclude that, in vivo, the C-terminal region facili-
tates phosphorylation of S-567 both by recruiting cyclin1998). In further support of this possibility, the D882
deletion, which removes most of the RXL-like docking E±Cdk2 to the pocket through the RXL-like docking site
and by promoting access to S-567. However, in vitro,sites from the C-terminal region and prevents cyclin D
or E from derepressing Rb in transfection assays (Figure the high concentration of cyclin E±Cdk2 may obviate
Cell
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Figure 5. The C-Terminal Region of Rb Cooperates with Cyclin E±Cdk2 to Disrupt the A±B Interaction in the Pocket
ªGº and ªLº indicate Gal4 and LexA tags used for immunoprecipitation and Western blotting, respectively (Weintraub et al., 1995; Chow and
Dean, 1996; Chow et al., 1996; Luo et al., 1998). ªAº indicates domain A (amino acids 379±612), ªBº indicates domain B (amino acids 620±792),
ªCº indicates the C-terminal region (amino acids 767±928), and ªSPº indicates the small pocket (amino acids 379±792). ªDBº indicates the
lysine patch mutant, and ªCD4º indicates that phosphoacceptor sites 807, 811, 821, and 826 were mutated to alanine. Numbers in the construct
name in (H) indicate mutated phosphoacceptor sites. In (A±H), expression vectors were transfected into Rb(2) C33a cells as indicated and
cell extracts were immunoprecipitated with antibody to the Gal4 tag, and associated proteins were detected by Western blot for the LexA
tag (Experimental Procedures). In each panel, the top blot is the coimmunoprecipitation, the middle blot is a direct Western showing the level
of LexA-binding protein, and the bottom blot is a Western showing the amount of precipitated Gal4 protein.
the need for the RXL-like docking sites. As in vitro, the 5C), indicating that binding of unphosphorylated C-ter-
minal region is dependent upon interaction of the twoC-terminal region in trans also facilitated phosphoryla-
tion of the pocket in vivo (results not shown). domains. Mutation of the phosphoacceptor sites in the
C-terminal region or the lysine patch in pocket domain
B did not prevent this binding of unphosphorylatedThe C-Terminal Region has a Second
Phosphorylation-Independent C-terminal region to the pocket (Figures 5D±5G), demon-
strating that this binding does not involve the phos-Interaction with the Pocket
In Figures 1C and 1D, we provided evidence that the phoacceptor sites or the lysine patch. However, when
the C-terminal region was phosphorylated, binding tophosphorylated C-terminal region can bind the pocket
and inhibit HDAC binding. However, we also detected the pocket increased in vitro and in vivo (Figures 4B,
4C, and 5G). Mutation of the lysine patch in the pocketbinding of the unphosphorylated C-terminal region to
the pocket in vivo and in vitro (Figures 1C, 4B, 4C, and prevented preferential binding to the phosphorylated
C-terminal region (Figure 5G). These results provide evi-5A). Similarly, when domains A and B were expressed
on separate proteins, the unphosphorylated C-terminal dence that the lysine patch mediates interaction of the
phosphorylated C-terminal region with the pocket.region was able to bind the A±B complex that reformed
(Figure 5B). However, as with HDAC, no binding was Taken together, our results suggest that the C-termi-
nal region makes two contacts with the pocket. Initially,detected to either pocket domain A or B alone (Figure
Regulation of Rb Functions by G1 Cdks
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Figure 6. The Cdk Phosphoacceptor Site at
S-567 Is Required for Cyclin E±Cdk2 to Pre-
vent Rb from Inactivating E2F
(A) Mutation of phosphoacceptor sites in
pocket domain B and in the spacer between
A and B does not prevent expression of cyclin
D or E from blocking active repression by Rb.
The pocket domain of Rb, with the indicated
mutations in phosphoacceptor sites, fused to
the DNA-binding domain of Gal4 was coex-
pressed in Rb(2) C33a cells, with the pSVEC-G
reporter containing Gal4-binding sites up-
stream of the SV40 enhancer to assess active
transcription repression as in Figures 1A and
1B. ªCº and ªCD4º indicate the C-terminal
region and the C-terminal region with four
phosphoacceptor sites mutated (in trans), re-
spectively. A diagram of the pocket showing
the position of mutated residues is shown
above.
(B) Elimination of S-567 as a Cdk phosphoac-
ceptor site prevents cyclin E±Cdk2 from
blocking the Rb inactivation of E2F. The mini-
mal E2F site reporter (Figure 3A) was cotrans-
fected into Rb(2) C33a cells along with ex-
pression vectors for Rb, D568, and cyclin D
or E, as indicated.
(C) The D568 mutation prevents cyclin E±Cdk2
from blocking binding of E2F-1 to Rb. The
experiment was similar to that shown in Fig-
ure 3B. The second blot is a direct Western
showing the level of input E2F-1, and the third
blot is a Western showing the level of precipi-
tated D568.
(D) The D568 mutation prevents cyclin E but
not cyclin D expression from inhibiting HDAC
binding. ªLPº indicates the Rb large pocket
(amino acids 379±928); ªWTº is wild type. As
in Figure 1C, Rb was immunoprecipitated and
associated HDAC1 was detected by Western
blot. The second blot is a Western showing
that the level of input HDAC was similar in
each assay.
phosphorylation of the C-terminal region causes it to Rb from binding and inactivating E2F by disrupting inter-
action between pocket domains A and B. In coimmuno-interact with the lysine patch in pocket domain B and
precipitation assays, binding of the unphosphorylatedinhibit HDAC binding. This initial interaction facilitates
C-terminal domain to the pocket did not disrupt thea second phosphorylation-independent interaction with
A±B interaction, nor was the A±B interaction significantlythe pocket that is required for cyclin E±Cdk2 phosphory-
affected when cyclin D was coexpressed in these assayslation of the pocket. These results provide an explana-
(Figures 5B and 5D±5F). However, expression of cyclintion for how phosphorylation by cyclin D±Cdk4/6 (which
E indeed led to disruption of the A±B interaction whentriggers the initial interaction) can facilitate phosphoryla-
the C-terminal region was coexpressed in trans (Figurestion by cyclin E±Cdk2 (which is dependent upon the
5B, 5D, and 5E).second interaction). It also provides a molecular basis
The binding site for E2F and HDAC on Rb are distinct,for the observation that both cyclin D±Cdk4/6 and cyclin
allowing a complex of HDAC-Rb-E2F to be targeted toE±Cdk2 are required for complete hyperphosphorylation
promoters (Brehm et al., 1998). We suggest that interac-of Rb. However, the effect of cyclin E-Cdk2-mediated
tion of phosphoacceptor sites on the C-terminal regionphosphorylation of the pocket was still unclear.
with the lysine patch blocks binding of Rb to HDAC,
thereby preventing active repression. However, the Rb±
Cyclin E±Cdk2 Disrupts Interaction of Pocket E2F complex persists, and subsequent phosphorylation
Domains A and B of the pocket by cyclin E±Cdk2 is required to disrupt
In contrast to the effect on active repression by Rb pocket structure and eliminate binding and inactivation
(Figure 1A), expression of cyclin E was more efficient of E2F. Therefore, we conclude that the ability of cyclin
than cyclin D in preventing Rb from inhibiting E2F (Figure E±Cdk2 to inhibit HDAC binding to the pocket (Figure
6A). Since it appeared that phosphorylation of the 1C) is due to disruption of the A±B interaction, which is
pocket by cyclin E±Cdk2 might mediate this effect, we required for formation of the LXCXE-binding site in
pocket domain B.wondered whether this phosphorylation might prevent
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Cyclin E±Cdk2 Appears to Disrupt the A±B
Interaction by Phosphorylation of S-567
at the A±B Interface
There are five consensus Cdk phosphoacceptor sites
within the pocket (S-567 in domain A, S-608 and S-612
in the spacer region between A and B, and S-780 and
S-788 in domain B) (Figure 6A). S-608, S-612, S-780,
and S-788 could all be mutated without affecting pocket
repressor activity (Figure 6A). We then asked whether
mutation of these phosphoacceptor sites in the pocket
would eliminate the ability of cyclin E±Cdk2 to block
repressor activity. For these assays, pocket constructs
with the phosphoacceptor sites mutated were coex-
pressed with cyclin E and the C-terminal region in trans
(with the four phosphoacceptor sites mutated in order
to eliminate the lysine patch interaction and make inhibi-
tion of pocket activity totally dependent upon cyclin
E±Cdk2). Mutation of these phosphoacceptor sites in
the pocket did not prevent cyclin E±Cdk2 from blocking
repressor activity (Figure 6A), and furthermore, cyclin
E±Cdk2 still disrupted the A±B interaction when these
sites were mutated (Figure 5H). These results suggest
that phosphorylation of S-608, S-612, S-780, or S-788
by cyclin E±Cdk2 does not affect pocket activity or struc-
ture. S-567 is phosphorylated by cyclin E±Cdk2 in vitro,
and this is dependent upon the C-terminal region,
whereas phosphorylation of the other Cdk phosphoac-
ceptor sites in the pocket is not (Figure 4A).
Figure 7. Phosphorylation of Rb Initiates Sequential IntramolecularThe phosphoacceptor site at S-567 could not be ex-
Interactions between the C-Terminal Region and the Pocket Domainamined directly because mutation of this residue (D567)
that Result in a Progressive Loss of Rb Functions as Cells Moveblocked Rb repressor activity (Figure 6A). In the consen-
through G1
sus Cdk phosphorylation sequence, the serine/threo-
See text for additional details.nine Cdk phosphoacceptor site is followed by a manda-
tory proline residue (Songyang et al., 1994; Holmes and
Solomon, 1996). Therefore, we mutated the proline at support of this possibility, we show that the cyclin E
amino acid 568 to an alanine (D568), thereby eliminating
effect on HDAC binding is eliminated with the D568 mu-
S-567 as a Cdk phosphoacceptor site. This mutant re-
tation (Figure 6D). The finding that cyclin D expression
tained full repressor activity (Figure 6A). To test the im-
inhibits HDAC binding to D568 further emphasized that
portance of S-567 as a potential phosphoacceptor site
cyclin D and E are acting through distinct mechanismsfor cyclin E±Cdk2, we cotransfected an expression vec-
and that the D568 mutation does not prevent cyclintor for D568 along with the reporter containing a minimal
D±dependent phosphorylation of the C-terminal regionpromoter and E2F sites. D568 efficiently blocked E2F
and its inhibition of HDAC binding to the pocket.transcriptional activation, but in contrast to the wild-type
S-567 is located in domain A at the A±B interface,protein, inactivation of E2F by D568 was not inhibited by
where it forms contacts with domain B (Lee et al., 1998).expression of cyclin E (Figure 6B). These results suggest
Phosphorylation of this site may then destabilize thethat phosphorylation of S-567 is important for cyclin
A±B interface and thus the A±B interaction. The sensitiveE±Cdk2 to disrupt pocket structure and block inactiva-
position of S-567 is further illustrated by the fact thattion of E2F.
missense mutations occur at this residue in tumors andThese results then predict that cyclin E expression
that these mutations disrupt Rb function (Templeton, etshould not block binding of D568 to E2F. Indeed, we
al., 1991).found that neither expression of cyclin E nor the combi-
nation of cyclin D and E was able to inhibit binding of
DiscussionE2F-1 to Rb (Figure 6C). However, we reasoned that
cyclin D expression should still be able to inhibit HDAC
A Model for Inhibition of Rb by G1 Cdksbinding, and we found that this was the case (Figure
Cdk4/6 and Cdk2 can both phosphorylate Rb and are6D). In Figure 1C, we showed that expression of cyclin
activated sequentially as cells progress through G1E could inhibit HDAC binding to the pocket when the
(Sherr, 1996). Previous studies have suggested thatC-terminal region was present in trans. In Figure 6D, we
phosphorylation by Cdk4/6 may facilitate phosphoryla-show that cyclin E can also disrupt binding of HDAC to
tion by Cdk2 and that both Cdks may be required for fullRb (where the C-terminal region is in cis), although not
hyperphosphorylation and inactivation of Rb (Lundbergas efficiently as cyclin D. Presumably, this effect of cyclin
and Weinberg, 1998). However, little is known of howE is to disrupt the A±B interaction in the pocket, resulting
phosphorylation affects Rb function and why phosphor-in loss of the HDAC-binding site, which is dependent
upon the A±B interaction (Luo et al., 1998). In further ylation by two different Cdks might be required during
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expression vectors were included in control assays. A phospho-G1. Here, we examined the mechanism of how Cdk
imager was used to quantitate CAT activity. Expression plasmidsphosphorylation regulates Rb activity. Our results sug-
include the following Gal4-tagged Rb proteins: Rb (amino acidsgest that phosphorylation of the C-terminal region of
379±928), Rb(A1B) (amino acids 379±792), RbC (amino acids 767±
Rb by cyclin D±Cdk4/6 triggers an initial intramolecular 928), and G-B (amino acids 620±792) (Chow and Dean, 1996). RbCD4
interaction with the central pocket domain that inhibits was created by subcloning an EcoRI fragment (amino acids 379±928)
from pSM.4 (which contains serine-to-alanine substitutions at S-807HDAC binding, thereby blocking active transcriptional
and S-811 and threonine-to-alanine substitutions at T-821 andrepression by the pocket (Figure 7). This interaction facil-
T-826; Knudsen and Wang, 1996) into the Gal4 DNA-binding domainitates a second phosphorylation-independent interac-
expression vector pM2 (Chow and Dean, 1996). The C-terminal re-tion of the C-terminal region with the pocket. The subse-
gion with the CD4 mutation was created by subcloning the SspI/
quent interaction is required for cyclin E±Cdk2 to access EcoRI (amino acids 767±928) fragment from RbCD4 into pM2.
S-567, which is buried at the A±B interface. Phosphory- RbD608/612 was created by deletion of the spacer sequence (amino
acids 602±646) between A and B (Chow and Dean, 1996). RbD780/lation of S-567 disrupts the A±B interface, preventing
788 was created by truncation of Rb(A1B) at amino acid 778 byRb from binding and inactivating E2F. In this model, the
PCR amplification of the cDNA-encoding amino acids 379±778 andRb functions of active repression and inactivation of
subcloning of the sequence back into pM2. G-BD780/788 was cre-E2F are lost successively through phosphorylation by
ated by subcloning amino acids 620±778 from RbD780/788 back
cyclin D±Cdk4/6 and then cyclin E±Cdk2, respectively. into pM2. Other Gal4-tagged proteins created by oligonucleotide-
Cyclin D±Cdk4/6 is likely to be the kinase that normally directed mutagenesis using the Mutagene in vitro mutagenesis kit
(Bio-Rad) include Rb(882) (stop codon introduced at position 882),disrupts HDAC binding and blocks active repression in
RbD713 (lysine to alanine), RbD713/729 (lysine to alanine), RbD713/vivo because it is activated in G1 before cyclin E±Cdk2
720/722 (lysine to alanine), RbD567 (serine to alanine), RbD568 (pro-(Sherr, 1996). If this is the case, then during the interval
line to alanine), and RbD608/612/780/788, which was created byin G1 between activation of cyclin D±Cdk4/6 and activa-
introducing a stop codon at residue 778 in construct RbD608/612.
tion of cyclin E±Cdk2, Rb is not able to actively repress LexA-tagged Rb proteins include L-A (amino acids 379±602) and
transcription, but it can still bind and inhibit E2F. Inacti- L-C (amino acids 767±928), described previously (Chow and Dean,
1996). Other vectors include RC.cyclin D2, RC.cyclin E, pCMV-vation of E2F would not be prevented until near the
dnCDK2, and pCMV.Cdk4 (van den Heuvel and Harlow, 1993).end of G1, when cyclin E±Cdk2 is activated. Such a
progressive loss of activities may allow differential regu-
lation of genes involved in cell cycle progression and/ In Vitro Phosphorylation
or apoptosis. Construction of GST-tagged Rb proteins GST-Rb(A1B) (amino acids
379±792) and GST-C (amino acids 767±928) and their purification
from bacteria was described previously (Hinds et al., 1992; Wein-
traub et al., 1995; Chow and Dean, 1996). Cyclin E±Cdk2 was purifiedPotential Rb Target Genes
from recombinant baculovirus-infected Sf9 cells (Xu et al., 1994).Recent studies suggest that expression of cyclin E is
Kinase reactions were performed in 50 ml of kinase buffer (50 mMgenetically downstream of cyclin D1 and that cyclin E
Tris-HCl [pH 7.5], 10 mM MgCl2, 1 mM DTT) with 150 mM ATP, 100
expression is sufficient to overcome the loss of cyclin D1 mCi of [g-32P]ATP, 20 ng of GST-Rb(A1B), and 30 ng of GST-C,
(Geng et al., 1996). We have recently used a dominant- as described (Xu et al., 1994). Reactions were incubated at room
temperature for 1 hr, resolved by SDS-PAGE, and detected by auto-negative form of E2F to displace HDAC-Rb-E2F from
radiography.promoters and provide evidence that this repressor
complex has a role in regulation of the G1/S transition
(Zhang et al., 1999). We suggest that active repression In Vivo Phosphorylation
by HDAC-Rb-E2F may have an important role in repress- Gal4-tagged constructs (20 mg) were transfected in C33a cells in
150 mm dishes. After 36 hr, media was removed and replaced withing cyclin E expression, which is required for assembly
5 ml of phosphate-free MEM containing 5% fetal calf serum dialyzedof origins of DNA replication and thus for S phase (Hua
against HEPES buffer for minimal phosphate content. Five millicu-and Newport, 1998), and this repression is overcome by
ries of [32P]orthophosphate per plate was then added for 6 hr. Cell
cyclin D±Cdk4/6. Interestingly, genes such as cyclin A lysates were then obtained, and Gal4 proteins were collected by
also have E2F sites, but their expression is delayed immunoprecipitation, resolved by SDS gel, and detected by autora-
until S phase. This raises the possibility that cyclin A diography.
expression may be dependent at least in some cases
upon transcriptional activation by E2F, such that its ex- Immunoprecipitations
pression is delayed in S phase until cyclin E±Cdk2 dis- C33A cells were transfected with 9 mg each of the indicated expres-
rupts the Rb±E2F complex, thereby releasing free E2F. sion vectors, and after 36 hr a protein extract was made, as de-
scribed previously (Chow et al., 1996; Luo et al., 1998). Ten percentIndeed, some cell types expressing dominant-negative
of the extract was used for direct Western blot, and the remainderE2F, which can also displace free E2F from the pro-
was immunoprecipitated with a monoclonal anti-Gal4 antibodymoter, are delayed in S phase.
(Santa Cruz) and Western blotted with a polyclonal anti-LexA anti-
body (Chow et al., 1996; Luo et al., 1998).
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